Free Trial

World Bank, Kommunalbanken on Tap

PIPELINE
World bank book over $8B, HSBC and Indonesia new to Tuesday's docket. GSK lead Monday's high-grade issuance w/$8.75B 7-pt package.
  • Date $MM Issuer (Priced *, Launch #)
  • 03/22 $Benchmark IBRD (World Bank) 2Y SOFR+12, 10Y SOFR+40
  • 03/22 $Benchmark Kommunalbanken 2.5Y SOFR+26
  • 03/22 $Benchmark HSBC 11NC10 +275a
  • 03/22 $Benchmark Indonesia 10Y 3.95%a, 30Y 4.6%a
  • $17.525B Priced Monday
  • 03/21 $8.75B *GlaxoSmithKline (GSK) $700M 2NC1 +90, $300M 2NC1 SOFR+89, $1.75B 3Y +90, $2B 5Y +110, $1B 7Y +115, $2B 10Y +135, $1B 30Y +158
  • 03/21 $4B *ING $1.25B 4NC3 +155, $500M 4NC3 SOFR+164, $1.25B 6NC5 +170, $1B 11NC10 +195
  • 03/21 $2.25B *Philippines Bnk $500M 5Y+90, $750M 10.5Y+125, $1B 25Y 4.2%
  • 03/21 $750M *Humana 7Y +137.5
  • 03/21 $525M *Union Electric 30Y +135
  • 03/21 $1.25B *Sempra 3Y +102, 7Y +140
  • 03/21 $Benchmark KEB Hana Bank 3Y, 5Y investor calls

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.